What You Should Know:
- Today, Komodo Health is capping off a month-long flurry of activity by announcing the launch of its Prism and Sentinel solutions — opening up access to its Healthcare Map to drive the next generation of AI innovation.
- Prism and Sentinel allows life sciences teams to tap into detailed patient behaviors and treatment patterns based on the real-world patient journeys of more than 325 million patients. The breakthrough software also allows life sciences teams to
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Biospecimen Procurement for R&D Needs to Look More Like an Online Marketplace
As healthcare digitizes everything from insurance claims to clinical decisions, some functions remain frustratingly analog, old school, and inefficient.
One such function is the distribution of human biospecimens necessary for medical research. Specimens are essential in providing much of the data that researchers examine, EHRs capture, and scientific databases aggregate. Unfortunately, the distribution of specimens and their data to researchers is woefully outdated and inefficient. Frankly,
Read More
Morehouse College, Verily Announces $575k Endowed Life Sciences Scholarship to Support STEM Careers
- Today, Verily announced a partnership with Morehouse College in Atlanta, GA, to establish an endowed award of $575,000 to fund a new Verily Scholars Program.
- The program will provide an annual scholarship to an exceptional Morehouse student majoring in STEM (Science, Technology, Mathematics, and Engineering) careers and will also fund up to three annual all-expenses paid summer internships at Verily. Verily looks forward to connecting Morehouse scholars to the biotech and
Read More
Janssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical Trials
What You Should Know:
- Komodo Health today announced a new client engagement with Janssen solidifying its role as the leading life sciences patient data analytics platform. Janssen Research & Development, LLC (Janssen) will be using Komodo's real-world data and AI software to accelerate clinical development. Janssen plans to use Komodo's services to optimize feasibility, site selection and patient recruitment for clinical trials, ultimately driving higher throughput for
Read More
Next-Generation Cloud Storage: Enabling Collaboration & Analytics for Pharma Research
Pharmaceutical companies today are distributed, global organizations, with research centers, manufacturing facilities, and regulatory management hubs spread all over the globe. To develop new treatments and bring them to market, all of these different functions need to collaborate more closely than ever. Using traditional, on-premises storage technologies, however, makes it difficult to share data quickly and securely, especially given that the research and manufacturing process can generate
Read More
Why Families Need the Closure Whole Genome Sequencing Provides
For medical practitioners expertly trained in the scientific methods of discovery, having a young patient with serious health complications from an undiagnosed condition is about as somber and frustrating as it gets. These feelings are only magnified for parents of the patient, especially when searching for a diagnosis can go on for years. This is the essence of what is known as the “diagnostic odyssey.”
Honing in on a rare disease diagnosis involves thorough medical history evaluations,
Read More
Komodo Health Secures $220M for Life Sciences Data Platform at $3.3B Valuation
What You Should Know:
- Komodo Health announces $220M Series E investment to advance its enterprise healthcare and life sciences platform. At a $3.3 billion valuation, the investment underscores the company's rapidly growing role as a foundational enterprise technology platform helping to drive digital transformation across the healthcare industry.
- Founded in 2014, Komodo Health’s Healthcare Map™ is the industry’s largest and most complete record of
Read More
Variantyx Lands $20M for Whole Genome Sequencing Methodology
What You Should Know:
- Variantyx, a Boston-based provider of high complexity hereditary disease testing, today announced that they secured $20M in funding for their Whole Genome Sequencing (WGS)-based testing methodology, an advanced genetic testing method currently used to diagnose rare inherited and neurological disorders. The series C funding round was led by GHS Fund (Quark Venture LP and GF Securities) and includes new investor, IBM Ventures and current investors, Pitango
Read More
Exscientia Secures $100M To Expand AI Drug Discovery Platform
What You Should Know:
- Exscientia, leading AI drug discovery company, today announced that it completed its $100 million Series C financing round, with a further $30 million investment from Blackrock.
- This new capital, which will be used to support Exscientia's platform development and proprietary pipeline, follows Exscientia’s demonstrated high growth, having announced earlier this year that the first ever precision engineered drug designed using AI had entered Phase I human clinical
Read More
Life Sciences Firm OrbiMed Raises $3.5B Across Private Investment Funds
What You Should Know:
Life sciences investment firm OrbiMed announced $3.5 billion in commitments for its latest private investment funds, including $1.5 billion for OrbiMed Private Investments VIII, $800 million for OrbiMed Asia Partners IV, and $1.2 billion for OrbiMed Royalty & Credit Opportunities III.
The three new funds include a broad range of medical institutions, university endowments, foundations, pension funds and sovereign wealth funds.
- OrbiMed Private Investments
Read More
